Skip to main content
Premium Trial:

Request an Annual Quote

Richard Popp, Paul Markham, Bill Brundage, Ernie Fletcher, Gianfranco de Feo, Emily Winn-Deen, Joseph Smith, Margaret Tempero, Greg Lucier, Peter Wilver, Theo Melas-Kyriazi

Richard Popp joins Advanced Technology Ventures of Palo Alto, Calif., in the position of technology partner. Popp will retain his appointment as a professor of medicine in the division of cardiovascular disease at the Stanford University School of Medicine as well as the position of director of ethics and policy for the Stanford Program in Biodesign. He is also principal medical consultant for both Agilent Labs and HP Labs.

Paul Markham, a 10-year veteran in senior sales and marketing positions at GE Healthcare Information Technologies, joins TeraMedica of Milwaukee, Wisc., as vice president of marketing. Markham will manage sales and marketing, and will oversee the brand development of the TeraMedica Information Solution, an enterprise archive solution that manages and converts medical records into digital images. TeraMedica was incorporated in 2001 and is a subsidiary of the radiology informatics laboratory of the Mayo Clinic.

Bill Brundage, Kentucky’s first commissioner of the new economy, has accepted a $50,000 contract to run through June 30, 2005, to facilitate technology transfer form the University of Louisville’s research efforts, according to a report in the Louisville Business First publication. His previous duties ended in July when Kentucky Gov. Ernie Fletcher restructured the organization, renaming it the Economic Development Cabinet’s Department of Innovation and Commercialization for the Knowledge-Based Economy. In his previous duties, Brundage’s office supported the university’s development of a proteomics program; expansion of the James Graham Brown Cancer Center; and development of the Cardiovascular Innovation Institute.

Gianfranco de Feo, former associate director for genomics collaborations at Affymetrix, joined Guava Technologies of Hayward, Calif., as director of customer support and service, the company said this week. Previously, he was a field application specialist at PerkinElmer/Applied Biosystems.

Emily Winn-Deen joins Cepheid of Sunnyvale, Calif., in the new position of vice president of strategic planning and business development, reporting to Joseph Smith, senior vice president for legal and business development, the company said. Winn-Deen joined Cepheid from her post as head of the genomics business group at Roche Molecular Systems in Pleasanton, Calif. Previously, she worked at Applied Biosystems and Celera Genomics, where she established Celera’s high-throughput genotyping laboratory, and the genotyping services business.

Margaret Tempero and Greg Lucier have been named keynote speakers at the BIO Emerging Company Investor Forum Oct. 13-15 in San Francisco. Tempero is director of clinical services and deputy director of the Comprehensive Cancer Center of the University of California at San Francisco and a professor and chief of the division of medical oncology. Lucier is the chairman and chief executive officer of Invitrogen.

Peter Wilver has replaced Theo Melas-Kyriazi as chief financial officer of Thermo Electron, the company said in an SEC filing this week. Melas-Kyriazi had announced his resignation in June, effective Oct. 1. Wilver takes the CFO post after serving as Thermo’s vice president of financial operations since October 2000, Previously, he was vice president and chief financial officer of Honeywell International’s electronic materials division and served as finance director of its aerospace aftermarket services business.

The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.